Form 4: ALX Oncology Holdings Inc. Executive Sells Shares to Cover Tax Obligations

Jaume Pons, President & CSO of ALX Oncology Holdings Inc., sold 10,758 shares of common stock on July 1, 2024, to satisfy tax obligations related to vesting restricted stock units.

Summary

• On July 1, 2024, Jaume Pons, the President & CSO of ALX Oncology Holdings Inc., sold 10,758 shares of common stock.
• The sale was executed to cover tax obligations arising from the vesting of restricted stock units.
• The shares were sold at a weighted average price of $5.8188, with individual transactions ranging from $5.78 to $5.82.
• Following the transaction, Jaume Pons directly owns 593,447 shares of ALX Oncology Holdings Inc.

Sentiment

Score: 5

Explanation: The document is a standard SEC Form 4 filing, indicating a routine transaction. The sentiment is neutral as it reflects an executive selling shares for tax purposes, which is a common practice.

Industry Context

Executive stock sales are a common occurrence, often related to compensation and tax planning. The sale itself doesn't necessarily indicate a negative outlook for the company, but it's a transaction investors monitor for insight into executive sentiment.

Stakeholder Impact

• The stock sale may have a minor impact on shareholders due to the increased supply of shares in the market, but the effect is likely minimal given the relatively small number of shares sold.

Key Dates